Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going?

The management of chronic hepatitis B virus (CHB) infection is an area of massive unmet clinical need worldwide. In spite of the development of powerful nucleoside/nucleotide analogue (NUC) drugs, and the widespread use of immune stimulators such as interferon-alpha (IFNα) or PEGylated interferon-al...

Descripción completa

Detalles Bibliográficos
Autores principales: Duraisamy, Ganesh Selvaraj, Bhosale, Dattatry, Lipenská, Ivana, Huvarova, Ivana, Růžek, Daniel, Windisch, Marc P., Miller, Andrew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552065/
https://www.ncbi.nlm.nih.gov/pubmed/32906840
http://dx.doi.org/10.3390/v12090998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552065/
https://www.ncbi.nlm.nih.gov/pubmed/32906840
http://dx.doi.org/10.3390/v12090998

Ejemplares similares